In Allergan Inc. v. Merz Pharmaceuticals LLC et al., Central District of California Judge Andrew J. Guilford barred Botox competitor, Merz Pharmaceuticals LLC, from selling wrinkle-reducing drug Xeomin. Botox maker, Allergan Inc., filed the case accusing seven of its former employees and Merz, of misappropriating trade secrets and violating the Lanham Act. In its suit, […]
Category Archives: Trademark
Botox Rival Barred From Selling Its Products After Employees’ Trade Secret Theft
MGA’s Antitrust Claims Against Mattel Over Bratz Doll Dismissed While IP Dispute Continues
Central District of California federal judge David O. Carter dismissed MGA Entertainment Inc.’s claims that Mattel Inc. attempted to sabotage its Bratz doll line, ruling that MGA’s lawsuit against Mattel relied on the same factual allegations that were raised during a 2010 trial resolving an intellectual property dispute over the Bratz doll line. The new […]
Optometrist’s Antitrust Counterclaims Dismissed in a Contact Lens Trademark Infringement Suit
In Ciba Vision Corp. v. De Spirito, Northern District of Georgia Judge J. Owen Forrester has dismissed an optometrist’s antitrust and other counterclaims in a trademark infringement suit brought by eye care company Ciba Vision Corp., holding that the defendant failed to sufficiently allege that Ciba engaged in any type of conspiracy in violation of […]
IBM Acused of Monopolizing Mainframe Market
Neon Enterprise Software has sued IBM in the Western District of Texas arguing that the mainframe computer giant has engaged in unfair competition in telling customers that they may not use a Neon software product. According to the complaint, mainframe customers with legacy systems are effectively locked into paying IBM large licensing fees. In recent […]